Carfilzomib-induced thrombotic microangiopathy (TMA) refractory to eculizumab: A case report and literature review
Crossref DOI link: https://doi.org/10.1007/s00277-024-05965-9
Published Online: 2024-08-27
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Meseha, Mina
Qu, Dan
Lykon, Jill
Coffey, David
Text and Data Mining valid from 2024-08-27
Version of Record valid from 2024-08-27
Article History
Received: 8 June 2024
Accepted: 20 August 2024
First Online: 27 August 2024
Declarations
:
: The authors declare no competing interests.